Carfentanyl
| Carfentanyl | |
|---|---|
| Salts [] | |
|---|---|
| Carfentanyl citrate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 394.50 g/mol [1] |
| Predicted LogP | 3.8 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C24H30N2O3 |
| IUPAC name | methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate |
| SMILES | CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CC=C3)C(=O)OC |
| InChI | InChI=1S/C24H30N2O3/c1-3-22(27)26(21-12-8-5-9-13-21)24(23(28)29-2)15-18-25(19-16-24)17-14-20-10-6-4-7-11-20/h4-13H,3,14-19H2,1-2H3 |
| InChIKey | YDSDEBIZUNNPOB-UHFFFAOYSA-N |
| CAS number | 59708-52-0 |
| UNII | LA9DTA2L8F |
| PubChem CID | 62156 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 7.7 hours |
Carfentanyl (also known as Wildnil, Carfentanilum, carfentanilo, Carfentanila, 4-carbomethoxyfentanyl, (4-carbomethoxy fentanyl), Methyl 1-phenylethyl-4-(N-phenylpropionamido)isonipecotate, R 31833, Methyl 4-(N-propionyl-N-phenylamino)-1-(2-phenylethyl)-4-piperidine-carboxylate or R-31833) is a anaesthetic and opioid substance of the amino acid and phenethylpiperidine class.
Chemistry
Salts []
Stereochemistry []
Carfentanyl is achiral.
Druglikeness
Lipinski's rule of five
Carfentanyl matches Lipinski's rule of five.Pharmacology
MeSH Classification
- analgesics, opioid (M0001068)
Mechanism of action []
Carfentanil binds very strongly to mu opioid receptors and acts as a competitive agonist. Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability. [1]
Subjective effects []
Legal status []
- Australia: Carfentanyl is a Schedule 8.
- Brazil: Carfentanyl is a F1.
- Canada: Carfentanyl is a Schedule I.
- United Kingdom: Carfentanyl is a Class A under the "Misuse of Drugs Act 1971".
- United States: Carfentanyl is a Schedule II under the "Controlled Substances Act".
- Germany: Carfentanyl is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
- Other: Carfentanyl is a <u>IN</u>: Schedule X (Veterinary use only).
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 62156, Carfentanyl. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/62156
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Carfentanyl. UNII: LA9DTA2L8F. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/LA9DTA2L8F
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 16:02:22 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 16:02:18 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 16:02:18 |
| gsrs | ok | 2026-11-20 16:02:19 |
| hmdb | missing (no HMDB id) | 2026-11-20 16:02:18 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 16:02:22 |
| pubchem | ok | 2026-11-20 16:02:18 |
| missing (no r/tripreports posts mention it) | 2026-11-20 16:02:18 | |
| sider | missing (not in SIDER) | 2026-11-20 16:02:18 |
| structure | ok | 2026-11-20 16:02:18 |
| wikipedia | ok | 2026-11-20 16:02:18 |